Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
175 | Journal of Experimental Therapeutics and Oncology | journal | 0.108 Q4 | 40 | 0 | 5 | 0 | 0 | 4 | 0.00 | 0.00 | 0.00 | |
174 | Molecular and Cellular Pharmacology | journal | 0.133 Q4 | 28 | 3 | 5 | 15 | 0 | 1 | 0.00 | 5.00 | 0.00 | |
173 | NTP Developmental and Reproductive Toxicity Technical Report Series | book series | 0.111 Q4 | 1 | 0 | 11 | 0 | 0 | 3 | 0.00 | 0.00 | 0.00 | |
172 | NTP Immunotoxicity Technical Report Series | book series | 0.133 Q4 | 0 | 0 | 3 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
171 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 0.111 Q4 | 9 | 2 | 3 | 348 | 0 | 3 | 0.00 | 174.00 | 63.24 | |
170 | Pharmaceutical Outsourcing | journal | 0.103 Q4 | 7 | 0 | 15 | 0 | 0 | 12 | 0.00 | 0.00 | 0.00 | |
169 | Journal of Caffeine and Adenosine Research | journal | 0.112 Q4 | 1 | 0 | 8 | 0 | 1 | 5 | 0.13 | 0.00 | 0.00 | |
168 | National Toxicology Program technical report series | journal | 0.111 Q4 | 22 | 2 | 5 | 185 | 1 | 5 | 0.00 | 92.50 | 0.00 | |
167 | NTP Research Report Series | book series | 0.117 Q4 | 3 | 1 | 4 | 21 | 1 | 4 | 0.00 | 21.00 | 0.00 | |
166 | Pharmacy Times | trade journal | 0.100 Q4 | 8 | 62 | 341 | 387 | 1 | 233 | 0.00 | 6.24 | 63.16 | |
165 | Drug Topics | journal | 0.104 Q4 | 8 | 104 | 412 | 180 | 2 | 71 | 0.01 | 1.73 | 63.64 | |
164 | NTP Technical Report on the Toxicity Studies Series | book series | 0.110 Q4 | 6 | 2 | 10 | 191 | 2 | 9 | 0.14 | 95.50 | 50.00 | |
163 | American Pharmaceutical Review | journal | 0.103 Q4 | 26 | 0 | 29 | 0 | 4 | 27 | 0.00 | 0.00 | 0.00 | |
162 | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | journal | 0.115 Q4 | 31 | 0 | 10 | 0 | 4 | 10 | 0.00 | 0.00 | 0.00 | |
161 | Food and Drug Law Journal | journal | 0.145 Q4 | 23 | 12 | 14 | 1814 | 4 | 14 | 0.29 | 151.17 | 34.62 | |
160 | Adverse Drug Reaction Bulletin | journal | 0.126 Q4 | 8 | 6 | 18 | 196 | 5 | 18 | 0.17 | 32.67 | 55.56 | |
159 | Drug Development and Delivery | trade journal | 0.104 Q4 | 12 | 79 | 198 | 606 | 5 | 89 | 0.02 | 7.67 | 32.14 | |
158 | Pharmaceutical Technology Europe | journal | 0.111 Q4 | 19 | 127 | 287 | 630 | 8 | 227 | 0.03 | 4.96 | 53.23 | |
157 | WikiJournal of Medicine | journal | 0.134 Q4 | 4 | 5 | 14 | 385 | 9 | 14 | 0.50 | 77.00 | 64.71 | |
156 | Journal of Excipients and Food Chemicals | journal | 0.128 Q4 | 17 | 10 | 30 | 330 | 10 | 19 | 0.41 | 33.00 | 40.74 | |
155 | BioPharm International | trade journal | 0.106 Q4 | 32 | 112 | 274 | 423 | 17 | 89 | 0.06 | 3.78 | 35.85 | |
154 | Cancer Innovation | journal | 0.389 Q2 | 4 | 56 | 20 | 3056 | 23 | 19 | 1.15 | 54.57 | 41.16 | |
153 | Current Protocols in Pharmacology | journal | 0.670 Q2 | 39 | 0 | 11 | 0 | 30 | 11 | 0.00 | 0.00 | 0.00 | |
152 | Pharmaceutical Technology | journal | 0.138 Q4 | 42 | 116 | 377 | 509 | 31 | 159 | 0.09 | 4.39 | 51.16 | |
151 | Precision Nanomedicine | journal | 0.219 Q3 | 6 | 14 | 43 | 1070 | 42 | 41 | 1.13 | 76.43 | 37.29 | |
150 | International Journal of Pharmaceutical Compounding | journal | 0.130 Q4 | 13 | 10 | 204 | 0 | 53 | 195 | 0.26 | 0.00 | 41.18 | |
149 | Dissolution Technologies | journal | 0.218 Q3 | 36 | 27 | 69 | 806 | 61 | 65 | 0.90 | 29.85 | 40.34 | |
148 | Topics in antiviral medicine | journal | 0.614 Q2 | 46 | 18 | 36 | 403 | 63 | 36 | 1.89 | 22.39 | 46.43 | |
147 | U.S. Pharmacist | trade journal | 0.128 Q4 | 12 | 126 | 375 | 1108 | 65 | 247 | 0.18 | 8.79 | 76.51 | |
146 | Applied In Vitro Toxicology | journal | 0.321 Q3 | 15 | 16 | 48 | 582 | 67 | 39 | 1.53 | 36.38 | 35.09 | |
145 | PDA Journal of Pharmaceutical Science and Technology | journal | 0.152 Q3 | 43 | 0 | 113 | 0 | 73 | 104 | 0.55 | 0.00 | 0.00 | |
144 | Mental Health Clinician | journal | 0.356 Q2 | 23 | 8 | 89 | 238 | 105 | 89 | 1.24 | 29.75 | 62.22 | |
143 | Current Cardiovascular Risk Reports | journal | 0.491 Q3 | 34 | 21 | 72 | 1537 | 119 | 72 | 1.94 | 73.19 | 38.46 | |
142 | Clinical Neuropharmacology | journal | 0.287 Q3 | 85 | 44 | 156 | 1416 | 149 | 146 | 0.81 | 32.18 | 42.79 | |
141 | Journal of Pharmacy Technology | journal | 0.330 Q3 | 16 | 52 | 133 | 1092 | 149 | 118 | 1.07 | 21.00 | 58.52 | |
140 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.255 Q3 | 34 | 32 | 88 | 1098 | 151 | 88 | 1.45 | 34.31 | 49.14 | |
139 | Medical Letter on Drugs and Therapeutics | journal | 0.239 Q3 | 22 | 149 | 346 | 932 | 168 | 239 | 0.49 | 6.26 | 48.00 | |
138 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.536 Q2 | 82 | 17 | 53 | 3290 | 172 | 53 | 2.83 | 193.53 | 37.14 | |
137 | Journal of Environmental Pathology, Toxicology and Oncology | journal | 0.415 Q3 | 50 | 25 | 87 | 1741 | 172 | 87 | 1.75 | 69.64 | 37.80 | |
136 | Journal of Immunotoxicology | journal | 0.711 Q2 | 48 | 9 | 54 | 432 | 176 | 54 | 2.21 | 48.00 | 54.05 | |
135 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.688 Q2 | 29 | 7 | 21 | 562 | 185 | 7 | 10.64 | 80.29 | 0.00 | |
134 | PPAR Research | journal | 0.698 Q2 | 59 | 15 | 69 | 877 | 199 | 69 | 3.25 | 58.47 | 38.10 | |
133 | Pharmacogenetics and Genomics | journal | 0.563 Q1 | 152 | 25 | 97 | 907 | 208 | 95 | 1.94 | 36.28 | 51.45 | |
132 | Current Therapeutic Research | journal | 0.495 Q3 | 46 | 37 | 110 | 1384 | 214 | 108 | 1.60 | 37.41 | 41.15 | |
131 | Canadian Pharmacists Journal | journal | 0.360 Q2 | 30 | 58 | 188 | 1152 | 215 | 112 | 1.09 | 19.86 | 64.79 | |
130 | Assay and Drug Development Technologies | journal | 0.317 Q3 | 65 | 32 | 126 | 1530 | 234 | 118 | 1.61 | 47.81 | 37.21 | |
129 | ACS Bio and Med Chem Au | journal | 1.036 Q1 | 11 | 48 | 62 | 3007 | 245 | 58 | 3.95 | 62.65 | 39.51 | |
128 | Journal of Pharmacological and Toxicological Methods | journal | 0.428 Q3 | 83 | 48 | 165 | 2160 | 250 | 162 | 1.29 | 45.00 | 38.46 | |
127 | Journal of Biopharmaceutical Statistics | journal | 0.812 Q2 | 56 | 110 | 203 | 3340 | 285 | 189 | 1.07 | 30.36 | 41.32 | |
126 | Hospital Pharmacy | journal | 0.308 Q3 | 28 | 110 | 307 | 2615 | 286 | 273 | 0.90 | 23.77 | 53.11 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®